Postpartum depression is a problem for almost 1 out of every 7 women and nearly one-quarter of mothers are depressed at some point in the first year after delivery, according to a study in JAMA Psychiatry.
Postpartum depression is a problem for almost 1 out of every 7 women and nearly one-quarter of mothers are depressed at some point in the first year after delivery, according to a study in JAMA Psychiatry.
Using the Edinburgh Postnatal Depression Scale (EPDS), researchers at an urban academic women’s hospital in Pittsburgh screened 10,000 women for depression at 4 to 6 weeks postpartum. The EPDS assesses self-harm ideation with statements and responses such as “The thought of harming myself has occurred to me” with responses to choose from including “yes, quite often;” “sometimes;” “hardly ever;” and “never.” Women who scored 10 or higher on the telephone screening were evaluated during home visits with the Structured Clinical Interview for DMS-IV for Axis I primary and secondary diagnoses.
Of the women who underwent EPDS screening, 1,396 (14%) had positive findings, of whom 826 (59.2%) completed home visits and 147 (10.5%) completed a telephone diagnostic interview. Positive screening was more likely in new mothers who were younger, African American, publicly insured, single, and less well educated. In 40% of the women with depression, the episodes started after delivery, compared with during pregnancy for 33.4% and before conception in 26.5% of women.
Self-harm ideation was documented in 19.3% of women who had suffered from depression. Unipolar depressive disorders and comorbid anxiety disorders were the most common primary diagnoses and 22.6% had bipolar disorders. Strategies to differentiate women with biopolar disorder from unipolar disorders, the authors said, are needed.
SART data indicates rise in IVF use in 2022
April 24th 2024Dive into the latest statistics from the Society for Assisted Reproductive Technology, revealing a 6% increase in in vitro fertilization cycles and a surge in egg freezing, amidst a landscape of rising fertility service demand and evolving clinical practices.
Read More
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More